---
$id: https://graph.org.ai/products/commodity/51111728
$type: Product
source: UNSPSC
code: "51111728"
title: "Cabazitaxel"
class: "51111700"
classTitle: "Antineoplastic antibiotics"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cabazitaxel

**UNSPSC Code**: 51111728
**Class**: [Antineoplastic antibiotics](Antineoplastic antibiotics.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a taxane compound and taxane-site binding agent with the molecular formula C45H57NO14, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 51F690397J. European Medicines Agency schedules cabazitaxel in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB31282. The term CABAZITAXEL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 22, no. 3, 2008, list 60). Most nations schedule cabazitaxel under HS 29329990 and SITC 51569. As of Q4 2014, CABAZITAXEL remains the US FDA Preferred Term for this commodity. Cabazitaxel bears US NLM identifiers UMLS ID C2830183 and NCI Concept Code C66937. SMILES: CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)OC)C)OC.

